Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

June 28, 2024

From Verve Therapeutics

Via GlobeNewswire

Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Drops Below Key $62K Level ↗

June 24, 2024

On Monday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc. (NASDAQ:COIN) taking the spotlight. This comes amidst a turbulent market scenario, particularly for...

Via Benzinga

Cathie Wood-Led Ark Invest Sells $1.5M Worth Of Robinhood Shares Amid Muted Bitcoin Market — Also Dumps Zoom Stock Worth $3.3M ↗

June 12, 2024

Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving Robinhood Markets Inc (NASDAQ:HOOD) and Zoom Video Communications Inc (NASDAQ:ZM).

Via Benzinga

Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness ↗

June 10, 2024

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a...

Via Benzinga

After a Serious Setback, Is Verve Therapeutics a Buy? ↗

April 06, 2024

There are a few silver linings at play here.

Via The Motley Fool

Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock ↗

June 06, 2024

Via Benzinga

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 31, 2024

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics Announces Leadership Update

May 31, 2024

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

May 30, 2024

From Verve Therapeutics

Via GlobeNewswire

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 ↗

May 17, 2024

Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.

Via InvestorPlace

3 Underappreciated Stocks That Could 10x in 10 Years ↗

May 12, 2024

10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.

Via InvestorPlace

VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

VERV stock results show that Verve Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

May 08, 2024

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

May 07, 2024

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 03, 2024

From Verve Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 23, 2024

Via Benzinga

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter ↗

April 11, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade ↗

April 04, 2024

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s positive market performance on the same day. The COIN Trade

Via Benzinga

Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor ↗

April 03, 2024

Via Benzinga

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher ↗

April 02, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500...

Via Benzinga

Topics Stocks

Dow Stumbles, Heads For Worst Day Since February ↗

April 02, 2024

Stocks are starting the second quarter off on the wrong foot, as profit taking grips Wall Street.

Via Talk Markets

Topics Stocks

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 02, 2024

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 02, 2024

Via Benzinga

Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol ↗

April 02, 2024

Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with...

Via Benzinga

Crude Oil Surges Over 1%; US Factory Orders Increase In February ↗

April 02, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 1.05% to 39,152.47 while the NASDAQ fell 1.17% to 16,205.37. The S&P 500...

Via Benzinga

Topics Stocks

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

April 02, 2024

From Schall Law

Via GlobeNewswire

Verve Plummets To Record Low After Its Gene-Editing Drug Causes Side Effects ↗

April 02, 2024

The company is now pausing enrollment in the study of its lead asset, VERVE-101.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 02, 2024

Via Benzinga

Verve Therapeutics Announces Updates on its PCSK9 Program

April 02, 2024

From Verve Therapeutics

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.